PREDICTORS OF ALL-CAUSE MORTALITY IN THE AIM-HIGH TRIAL IDENTIFIED BY MACHINE LEARNING

Nuha Gani,Amit Dey, Victoria Xin,Runqiu Wang,Ruba Shalhoub,Colin Wu,Tian Xin, Eileen Navarro Almario,Tejas Patel,Jerome Fleg,Anna Kettermann,Gyorgy Csako,George Sopko, Helena Sviglin,Lawton Cooper,Laboni Hoque,Gauri Dandi,Iffat Chowdhury,Keith Burkhart,Karim Calis,Ana Szarfman,Nehal Mehta,Frank Pucino,Yves Rosenberg,Ahmed Hasan

Journal of the American College of Cardiology（2019）

引用 0|浏览54

暂无评分

摘要

The Bari Angioplasty Revascularization in Type 2 Diabetes (BARI 2D) Trial tested the effects of different treatment strategies on the rate of death and a composite of death, myocardial infarction, or stroke (MACE) in patients with both coronary artery disease and type 2 diabetes. We sought to

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要